Quidel | QDEL - Beneficio Bruto En Ventas

Precio De Mercado
21.66
Cambio Diario
0.47 2.22%
Mensual
-24.50%
Anual
-45.40%
Q1 Expectativa
22.04




Beneficio Bruto En Ventas Cambio Fecha
Abbott USD 6.54B 625M 2025-12
Agilent USD 946M 44M 2025-12
Avanos Medical USD 86M 0 2025-12
Becton, Dickinson and Co. USD 2.41B 1.72B 2025-12
Bruker USD 449.2M 69.8M 2025-12
Cerus USD 33.33M 8.66M 2024-12
Charles River Laboratories USD 271.96M 39.43M 2025-12
Danaher USD 3.97B 443M 2025-12
Exact Sciences USD 583.93M 21.48M 2025-09
Haemonetics USD 202.39M 7.64M 2025-12
Hologic USD 586.4M 2.9M 2025-12
Illumina USD 759M 26M 2025-12
IQVIA Holdings USD 1.12B 32M 2025-12
Merit Medical Systems USD 195.35M 8.94M 2025-12
Mettler Toledo International USD 675.44M 65.98M 2025-12
Myriad Genetics USD 143.8M 8M 2025-09
Neogen USD 94.97M 2.11M 2025-06
OraSure Technologies USD 17.07M 7.62M 2024-09
Pacific Biosciences Of California USD 10M 4.07M 2024-09
Quidel USD 274.8M 1.01B 2025-12
Revvity USD 421.66M 47.06M 2025-12
STAAR Surgical USD 43.74M 34.13M 2025-12
Thermo Fisher Scientific USD 4.64B 419M 2025-12
Waters USD 557.42M 97.44M 2025-12